Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
An amendment to this paper has been published and can be accessed via the original article.
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-01-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Online Access: | https://doi.org/10.1186/s13046-022-02247-y |
| _version_ | 1819231529229877248 |
|---|---|
| author | Ilaria Romito Manuela Porru Maria Rita Braghini Luca Pompili Nadia Panera Annalisa Crudele Daniela Gnani Cristiano De Stefanis Marco Scarsella Silvia Pomella Stefano Levi Mortera Emmanuel de Billy Adrian Libenzio Conti Valeria Marzano Lorenza Putignani Manlio Vinciguerra Clara Balsano Anna Pastore Rossella Rota Marco Tartaglia Carlo Leonetti Anna Alisi |
| author_facet | Ilaria Romito Manuela Porru Maria Rita Braghini Luca Pompili Nadia Panera Annalisa Crudele Daniela Gnani Cristiano De Stefanis Marco Scarsella Silvia Pomella Stefano Levi Mortera Emmanuel de Billy Adrian Libenzio Conti Valeria Marzano Lorenza Putignani Manlio Vinciguerra Clara Balsano Anna Pastore Rossella Rota Marco Tartaglia Carlo Leonetti Anna Alisi |
| author_sort | Ilaria Romito |
| collection | DOAJ |
| description | An amendment to this paper has been published and can be accessed via the original article. |
| first_indexed | 2024-12-23T11:46:25Z |
| format | Article |
| id | doaj.art-7ea489c1d2f64a7ea2dea114313c315d |
| institution | Directory Open Access Journal |
| issn | 1756-9966 |
| language | English |
| last_indexed | 2024-12-23T11:46:25Z |
| publishDate | 2022-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Experimental & Clinical Cancer Research |
| spelling | doaj.art-7ea489c1d2f64a7ea2dea114313c315d2022-12-21T17:48:20ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662022-01-014111610.1186/s13046-022-02247-yCorrection to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effectsIlaria Romito0Manuela Porru1Maria Rita Braghini2Luca Pompili3Nadia Panera4Annalisa Crudele5Daniela Gnani6Cristiano De Stefanis7Marco Scarsella8Silvia Pomella9Stefano Levi Mortera10Emmanuel de Billy11Adrian Libenzio Conti12Valeria Marzano13Lorenza Putignani14Manlio Vinciguerra15Clara Balsano16Anna Pastore17Rossella Rota18Marco Tartaglia19Carlo Leonetti20Anna Alisi21Unit of Molecular Genetics of Complex Phenotypes, Bambino Gesu Children’s Hospital, IRCCSUnit of Oncogenomic and Epigenetic, IRCCS Regina Elena National Cancer InstituteUnit of Molecular Genetics of Complex Phenotypes, Bambino Gesu Children’s Hospital, IRCCSUnit of Oncogenomic and Epigenetic, IRCCS Regina Elena National Cancer InstituteUnit of Molecular Genetics of Complex Phenotypes, Bambino Gesu Children’s Hospital, IRCCSUnit of Molecular Genetics of Complex Phenotypes, Bambino Gesu Children’s Hospital, IRCCSExperimental Imaging Center, IRCCS San Raffaele Scientific InstituteCore Facilities, Bambino Gesu Children’s HospitalCore Facilities, Bambino Gesu Children’s HospitalDepartment of Paediatric Haematology/Oncology and Cellular and Gene Therapy, Bambino Gesu Children’s Hospital, IRCCSUnit of Human Microbiome, Multimodal Laboratory Medicine Research Area, Bambino Gesu Children’s HospitalDepartment of Paediatric Haematology/Oncology and Cellular and Gene Therapy, Bambino Gesu Children’s Hospital, IRCCSCore Facilities, Bambino Gesu Children’s HospitalUnit of Human Microbiome, Multimodal Laboratory Medicine Research Area, Bambino Gesu Children’s HospitalUnit of Human Microbiome, Multimodal Laboratory Medicine Research Area, Bambino Gesu Children’s HospitalInternational Clinical Research Center, St. Anne’s University HospitalDepartment of Life, Health and Environmental Sciences MESVA, University of L’AquilaResearch Unit of Diagnostical and Management Innovations, Bambino Gesu Children’s Hospital, IRCCSDepartment of Paediatric Haematology/Oncology and Cellular and Gene Therapy, Bambino Gesu Children’s Hospital, IRCCSGenetics and Rare Diseases Research Division, Bambino Gesu Children’s Hospital, IRCCSUnit of Oncogenomic and Epigenetic, IRCCS Regina Elena National Cancer InstituteUnit of Molecular Genetics of Complex Phenotypes, Bambino Gesu Children’s Hospital, IRCCSAn amendment to this paper has been published and can be accessed via the original article.https://doi.org/10.1186/s13046-022-02247-y |
| spellingShingle | Ilaria Romito Manuela Porru Maria Rita Braghini Luca Pompili Nadia Panera Annalisa Crudele Daniela Gnani Cristiano De Stefanis Marco Scarsella Silvia Pomella Stefano Levi Mortera Emmanuel de Billy Adrian Libenzio Conti Valeria Marzano Lorenza Putignani Manlio Vinciguerra Clara Balsano Anna Pastore Rossella Rota Marco Tartaglia Carlo Leonetti Anna Alisi Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects Journal of Experimental & Clinical Cancer Research |
| title | Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title_full | Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title_fullStr | Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title_full_unstemmed | Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title_short | Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title_sort | correction to focal adhesion kinase inhibitor tae226 combined with sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| url | https://doi.org/10.1186/s13046-022-02247-y |
| work_keys_str_mv | AT ilariaromito correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT manuelaporru correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT mariaritabraghini correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT lucapompili correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT nadiapanera correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT annalisacrudele correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT danielagnani correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT cristianodestefanis correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT marcoscarsella correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT silviapomella correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT stefanolevimortera correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT emmanueldebilly correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT adrianlibenzioconti correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT valeriamarzano correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT lorenzaputignani correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT manliovinciguerra correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT clarabalsano correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT annapastore correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT rossellarota correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT marcotartaglia correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT carloleonetti correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT annaalisi correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects |